Home Mountain Henderson, NV Zura Bio COMPANY
Clinical Phase 2
5 open jobs · last seen Oct 23, 2026 · 3 sources
Keywords: immunology Systemic Sclerosis Scleroderma Hidradenitis Suppurativa Tibulizumab
Location: La Jolla, CA · source · Oct 13, 2026
Profile checked Oct 10, 2026
Hiring Title Location (from posting) Employer posted First seen Director, Clinical Operations United States Oct 8, 2026 Oct 9, 2026 Director, Clinical Medical Writing United States Oct 5, 2026 Oct 9, 2026 Director, Regulatory Medical Writing United States Oct 5, 2026 Oct 9, 2026 Senior Director, Investor Relations and Corporate Communications United States Sep 29, 2026 Oct 9, 2026 Director, Global Regulatory Strategy United States Sep 29, 2026 Oct 9, 2026
See all 5 jobs
At a glance HQ La Jolla, CA source Region Mountain Stage Clinical Phase 2 Latest trial Phase 2: Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense (May 16, 2025) source Timeline Oct 9, 2026 Board tracked Radar started tracking this company’s job board (5 open jobs at last check). source ↗ May 16, 2025 Trial start Phase 2: Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense source ↗ Feb 6, 2025 Trial start Phase 2: Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) source ↗ Upcoming milestones 2026-11 (ESTIMATED) · Phase 2 · Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense · NCT06993610 2027-05 (ESTIMATED) · Phase 2 · Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) · NCT06843239 Estimated primary completion per ClinicalTrials.gov. Dates move.
Open jobs 5 Title Location (from posting, not HQ) Employer posted First seen Level Director, Clinical Operations United States Oct 8, 2026 Oct 9, 2026 Senior Description Director, Clinical Medical Writing United States Oct 5, 2026 Oct 9, 2026 Senior Description Director, Regulatory Medical Writing United States Oct 5, 2026 Oct 9, 2026 Senior Description Senior Director, Investor Relations and Corporate Communications United States Sep 29, 2026 Oct 9, 2026 Senior Description Director, Global Regulatory Strategy United States Sep 29, 2026 Oct 9, 2026 Senior Description
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
Clinical trials (lead sponsor) 2 Record Title Phase Status Start Primary completion NCT06843239 Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) Phase 2 Active, not recruiting Feb 6, 2025 2027-05 (estimated) NCT06993610 Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense Phase 2 Active, not recruiting May 16, 2025 2026-11 (estimated)
Connect See your connections at Zura Bio on LinkedIn (search by name, results not checked) LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.
LinkedIn page linked from the company's own site: source · seen 2026-10-18
